Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Yasufumi Katanasaka(University of Shizuoka), Naoto Oku(University of Shizuoka), Shinichi Miyagawa(Tokyo University of Science), Norio Ohashi(University of Shizuoka), Tomohiro Asai(University of Shizuoka), Hirotaka Naitou(University of Shizuoka), Noriyuki Maeda(University of Shizuoka), Fumiaki Koizumi(Tokyo Metropolitan Komagome Hospital), Takayuki Ishii(Kanazawa University)
Cited by 111
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
|Journal of Biological Chemistry|1993|256